The global retractable needle safety syringe market is expected to grow due to product innovations and agreements

A retractable needle safety syringe is a type of safety syringe with a built-in safety mechanism. It is built such that the protruding needle is retracted into the syringe barrel when the medication/dose is delivered. To break the seal and retract the needle into the syringe, the user must apply extra pressure to the associated plunger after the medication has been discharged. Retractable needles are both safe and accurate. In comparison to other syringes, these syringes produce less waste. Retractable needle syringes are used to treat diabetes, TB, and cancer, among other conditions.

The increasing prevalence of chronic diseases, expanding geriatric population, and growing awareness among healthcare professionals are major factors driving the growth of the global retractable needle safety syringes market. According to the American Diabetes Association, around 30.3 million Americans had diabetes in 2015, accounting for 9.4 percent of the entire U.S. population. Furthermore, according to the World Health Organization (WHO), roughly 8.8 million people died from cancer worldwide in 2015. Cancer fatalities account for over 70% of all deaths in low and middle-income countries.

According to the World Health Organization (WHO), around 16 billion injections are administered each year, with nearly 90 percent administered in curative situations. The Retractable Needle Safety Syringes Market of syringes is documented globally, particularly in emerging nations, resulting in widespread infection among healthcare professionals and patients. Unsafe syringe use can result in hemorrhagic fevers such as the Marburg and Ebola viruses, as well as malaria and other diseases. According to WHO statistics from 2012, unsafe syringe use results in 1.3 million premature deaths each year, $535 million in direct medical costs, and a cumulative loss of 26 million years of life.